
Avidity Biosciences Investor Relations Material
Latest events

Investor Update
Avidity Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Avidity Biosciences Inc
Access all reports
Avidity Biosciences Inc is a biopharmaceutical company focused on developing a novel class of RNA therapeutics. These therapeutics, known as Antibody Oligonucleotide Conjugates (AOC™), are designed to target and treat a range of serious diseases by combining the specificity of monoclonal antibodies with the precision of oligonucleotides. This approach aims at addressing diseases previously untreatable with RNA therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Key slides for Avidity Biosciences Inc


Investor Update
Avidity Biosciences Inc


Investor Update
Avidity Biosciences Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
RNA
Country
🇺🇸 United States